Evidence map›Paper›PMID 15365616›Full record

ArticleDiabetologia2004

The Pal elements in the upstream glucokinase promoter exhibit dyad symmetry and display cell-specific enhancer activity when multimerised.

J M Moates, M A Magnuson

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Diabetologia, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Review
  2. Article
  3. Molecular and cellular regulation of human glucokinase.Archives of biochemistry and biophysics · 2019
    Review
  4. Article
  5. Article
  6. Molecular physiology of mammalian glucokinase.Cellular and molecular life sciences : CMLS · 2009
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

J M MoatesDepartment of Medicine, Vanderbilt University School of Medicine and The Nashville Veterans' Affairs Medical Center, Nashville, Tennessee, USA. mmoates@uab.edu.
M A Magnuson
University of Alabama at Birmingham · USVanderbilt University · US

Funding

GLUCOKINASE GENE EXPRESSION IN THE PANCREATIC BETA CELLR01DK042612 · NIDDK · VANDERBILT UNIVERSITY · PI MAGNUSON, MARK A · 1990 to 2005
$1.7M
NIDDK NIH HHS DK42502NIDDK NIH HHS DK42612
6 · The paper itself

Abstract

aims/hypothesisThe upstream glucokinase (betaGK) promoter has previously been shown to contain two 9-bp sequences, termed the Pal motifs, that are conserved in humans, rats and mice. These motifs are necessary for expression of the betaGK promoter in pancreatic beta cell lines and pituitary corticotrope cell lines. DNA probes containing the Pal motifs bind cell-type-specific protein complexes, but these motifs have not been completely characterised.

methodsMethylation interference and ultraviolet-crosslinking analysis were utilised to characterise, at the single nucleotide level, sites of protein binding within the elements themselves. To determine the function of these elements, mutational analysis of the betaGK promoter and of multimerised GK promoter sequences was performed.

resultsBoth Pal elements are 14 bp in length and have dyad symmetry. However, while the Pal-1 element is a perfect inverted repeat (GTCACCA-TGGTGAC), the Pal-2 element (GTCACCA-TAGAAAC) is an imperfect repeat. Ultraviolet-crosslinking analysis using nuclear extracts prepared from hamster insulinoma tumour (HIT) cells revealed that the three resolvable complexes that bind to the Pal-1 and Pal-2 elements contain different ratios of three proteins of different size (approximately 90, 110 and 150 M(r)). Mutation of a single nucleotide binding site abrogates betaGK promoter activity. Multimerised repeats of the Pal-1 element augment transcription in HIT cells, but not in baby hamster kidney (BHK) cells. CONCLUSIONS/

interpretationThese results suggest that different combinations of three proteins of different size bind to the Pal elements, probably as homodimers and heterodimers. Together, these results indicate that the betaGK promoter contains two novel 14-bp elements that, when multimerised, exhibit enhancer activity specific to neuroendocrine cells.

Indexed as

Enhancer Elements, GeneticPromoter Regions, GeneticAnimalsBase SequenceCell LineCricetinaeDNAGlucokinaseKidneyMacromolecular SubstancesMolecular Sequence DataMutagenesisPlasmidsPlasminogen Activator Inhibitor 1DNAGlucokinaseMacromolecular SubstancesPlasminogen Activator Inhibitor 1

Identifiers

PMID15365616
OpenAlexW1975593105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.